|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, Case Western Reserve University, Cleveland, Ohio, United States
2 Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
3 Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States; Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States; Anesthesiology, Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin, United States; Department of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin, United States; Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
4 Pharmacology, Case Western Reserve University, United States; Medicine, Case Western Reserve University, Cleveland, Ohio, United States
5 Medical Service, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio, United States; Medicine, Case Western Reserve University, Cleveland, Ohio, United States
* To whom correspondence should be addressed. E-mail: exl9{at}cwru.edu.
Mitochondria are increasingly recognized as lynchpins in the evolution of cardiac injury during ischemia and reperfusion. This review addresses the emerging concept that modulation of mitochondrial respiration during and immediately following an episode of ischemia can attenuate the extent of myocardial injury. The blockade of electron transport or the partial uncoupling of respiration are two mechanisms whereby manipulation of mitochondrial metabolism during ischemia decreases cardiac injury. Although protection by inhibition of electron transport or uncoupling of respiration initially appears to be counterintuitive, the continuation of mitochondrial oxidative phosphorylation in the pathologic milieu of ischemia generates reactive oxygen species, mitochondrial calcium overload, and the release of cytochrome c. The initial target of these deleterious mitochondrial-driven processes is the mitochondria themselves. Consequences to the cardiomyocyte, in turn, include oxidative damage, the onset of mitochondrial permeability transition, and activation of apoptotic cascades, all favoring cardiomyocyte death. Ischemia-induced mitochondrial damage carried forward into reperfusion further amplifies these mechanisms of mitochondrial-driven myocyte injury. Interruption of mitochondrial respiration during early reperfusion by pharmacologic blockade of electron transport or even recurrent hypoxia or brief ischemia paradoxically decreases cardiac injury. It increasingly appears that the cardioprotective paradigms of ischemic preconditioning and post-conditioning utilize modulation of mitochondrial oxidative metabolism as a key effector mechanism. The initially counterintuitive approach to inhibit mitochondrial respiration provides a new cardioprotective paradigm to decrease cellular injury during both ischemia and reperfusion.
This article has been cited by other articles:
![]() |
P. Pasdois, B. Beauvoit, L. Tariosse, B. Vinassa, S. Bonoron-Adele, and P. D. Santos Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: a study on Langendorff-perfused rat hearts using optic fibers Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2088 - H2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, S. Moghaddas, C. L. Hoppel, and E. J. Lesnefsky Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria Am J Physiol Cell Physiol, February 1, 2008; 294(2): C460 - C466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aldakkak, D. F. Stowe, Q. Chen, E. J. Lesnefsky, and A. K.S. Camara Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release Cardiovasc Res, January 15, 2008; 77(2): 406 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jahangir, S. Sagar, and A. Terzic Aging and cardioprotection J Appl Physiol, December 1, 2007; 103(6): 2120 - 2128. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heinen, M. Aldakkak, D. F. Stowe, S. S. Rhodes, M. L. Riess, S. G. Varadarajan, and A. K. S. Camara Reverse electron flow-induced ROS production is attenuated by activation of mitochondrial Ca2+-sensitive K+ channels Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1400 - H1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Westberg, M. Serlachius, P. Lankila, and L. C. Andersson Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1766 - H1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tanaka-Esposito, Q. Chen, S. Moghaddas, and E. J. Lesnefsky Ischemic preconditioning does not protect via blockade of electron transport J Appl Physiol, August 1, 2007; 103(2): 623 - 628. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |